Because Knetbooks knows college students. Our rental program is designed to save you time and money. Whether you need a textbook for a semester, quarter or even a summer session, we have an option for you. Simply select a rental period, enter your information and your book will be on its way!
| Foreword | p. xiii |
| Preface | p. xv |
| Acknowledgments | p. xvii |
| About the Authors | p. xix |
| Introduction to Pediatric Neuropsychology | p. 1 |
| What Is Pediatric Neuropsychology? | p. 1 |
| Neuropsychological Assessment | p. 3 |
| Interpretation | p. 9 |
| Why Neuropsychological Assessment? | p. 10 |
| Linking Assessment to Intervention | p. 1... MORE |
| Concluding Comments | p. 12 |
| Learning Disabilities: Reading Disability/Dyslexia | p. 15 |
| Definition | p. 15 |
| Etiology | p. 17 |
| Course and Prognosis | p. 23 |
| Evidence-Based Interventions | p. 25 |
| Case Study: Cord-Dyslexia | p. 28 |
| Concluding Comments | p. 39 |
| Learning Disabilities: Dyscalculia/Math Disability | p. 41 |
| Definition | p. 41 |
| Etiology | p. 44 |
| Course and Prognosis | p. 48 |
| Evidence-Based Interventions | p. 53 |
| Case Study: Carl-Dyscalculia | p. 53 |
| Concluding Comments | p. 62 |
| Specific Language Impairment/Dysphasia | p. 63 |
| Definition | p. 63 |
| Etiology | p. 66 |
| Course and Prognosis | p. 72 |
| Evidence-Based Interventions | p. 77 |
| Case Study: Naya-Dysphasia/SLI | p. 79 |
| Concluding Comments | p. 87 |
| Autism Spectrum Disorders | p. 89 |
| Definition | p. 89 |
| Etiology | p. 91 |
| Course and Prognosis | p. 100 |
| Evidence-Based Interventions | p. 106 |
| Case Study: John-Asperger's Disorder | p. 108 |
| Concluding Comments | p. 119 |
| Attention-Deficit/Hyperactivity Disorder | p. 121 |
| Definition | p. 121 |
| Etiology | p. 124 |
| Course and Prognosis | p. 127 |
| Evidence-Based Interventions | p. 129 |
| Case Study: Eddie-Attention-Deficit/Hyperactivity Disorder, Combined Type | p. 137 |
| Concluding Comments | p. 145 |
| Tourette Syndrome | p. 147 |
| Definition | p. 147 |
| Etiology | p. 148 |
| Course and Prognosis | p. 152 |
| Evidence-Based Interventions | p. 162 |
| Case Study: Moses-Tourette Syndrome | p. 167 |
| Concluding Comments | p. 178 |
| Traumatic Brain Injury | p. 181 |
| Definition | p. 181 |
| Course and Prognosis | p. 184 |
| Evidence-Based Interventions | p. 193 |
| Case Study: Gage-Traumatic Brain Injury | p. 198 |
| Concluding Comments | p. 206 |
| Childhood Cancer | p. 207 |
| Definition | p. 207 |
| Etiology | p. 209 |
| Course and Prognosis | p. 211 |
| Evidence-Based Interventions | p. 217 |
| Case Study: David-Lymphocytic Leukemia | p. 220 |
| Case Study: Jay-Astrocytoma | p. 228 |
| Concluding Comments | p. 236 |
| Epilepsy | p. 237 |
| Definition | p. 237 |
| Etiology | p. 239 |
| Course and Prognosis | p. 240 |
| Evidence-Based Interventions | p. 246 |
| Case Study: Zoey-Complex Partial Seizures with Temporal Lobe Origin | p. 251 |
| Case Study: Lane-Landau-Kleffner Syndrome (Epileptic Aphasia) | p. 260 |
| Concluding Comments | p. 272 |
| Cerebrovascular Disease: Focus on Sickle Cell Disease | p. 273 |
| Definition | p. 273 |
| Etiology | p. 274 |
| Course and Prognosis | p. 275 |
| Evidence-Based Interventions | p. 279 |
| Case Study: Lania-Sickle Cell Disease without Stroke | p. 281 |
| Case Study: Jed-Sickle Cell Disease with Stroke | p. 294 |
| Concluding Comments | p. 305 |
| Low Birth Weight | p. 307 |
| Definition | p. 307 |
| Etiology | p. 307 |
| Course and Prognosis | p. 309 |
| Evidence-Based Interventions | p. 317 |
| Case Study: Emily-Extremely Low Birth Weight | p. 322 |
| Concluding Comments | p. 332 |
| Environmental Toxin Exposure | p. 335 |
| Definition and Etiology | p. 335 |
| Course and Prognosis | p. 341 |
| Evidence-Based Interventions | p. 346 |
| Case Study: Demetric-Lead Exposure | p. 347 |
| Concluding Comments | p. 357 |
| Neurotoxins, Pregnancy, and Subsequent Disorders | p. 359 |
| Definition and Etiology | p. 359 |
| Course and Prognosis: FASD and Illicit Drugs | p. 366 |
| Case Study: Caleb-Fetal Alcohol Syndrome | p. 368 |
| Course and Prognosis: Antiepileptics and FVS | p. 377 |
| Case Study: Keisha-Fetal Valproate Syndrome | p. 378 |
| Evidence-Based Interventions | p. 384 |
| Concluding Comments | p. 385 |
| Chromosomal Anomalies | p. 387 |
| Autosomal Abnormalities: Down Syndrome | p. 387 |
| Fragile X | p. 392 |
| Williams Syndrome | p. 397 |
| Angelman Syndrome | p. 403 |
| Prader-Willi Syndrome | p. 407 |
| Case Study: George-Angelman Syndrome | p. 413 |
| Sex Chromosome Disorders | p. 417 |
| Case Study: Walter-Noonan Syndrome | p. 424 |
| Concluding Comments | p. 431 |
| Neurocutaneous Disorders | p. 433 |
| Neurofibromatosis | p. 433 |
| Case Study: Gino-Neurofibromatosis Type 1 | p. 438 |
| Tuberous Sclerosis Complex | p. 448 |
| Case Study: Hector-Tuberous Sclerosis | p. 452 |
| Sturge-Weber Syndrome | p. 463 |
| Case Study: Juliana-Sturge-Weber Syndrome | p. 466 |
| Concluding Comments | p. 475 |
| Metabolic Disorders | p. 477 |
| Type 1 Diabetes | p. 477 |
| Case Study: Sam-Type 1 Diabetes | p. 484 |
| Phenylketonuria | p. 494 |
| Case Study: Vinnie-PKU | p. 499 |
| Mucopolysaccharide Disorders | p. 512 |
| Concluding Comments | p. 514 |
| Looking Back, Looking Forward | p. 517 |
| Assessment to Intervention Planning in Pediatric Neuropsychology | p. 517 |
| Summary of Intervention Issues | p. 525 |
| Conclusion and Future Directions | p. 527 |
| References | p. 529 |
| Author Index | p. 687 |
| Subject Index | p. 709 |
| Table of Contents provided by Ingram. All Rights Reserved. |